International Conference on
Alzheimers and Dementia Diseases
Theme: “Innovations and Advances in Alzheimer’s and Dementia Research”
July 21-22, 2025 | Vancouver, Canada
About Alzheimers Dementia Diseases
We take the pleasure in inviting you to participate in the International Conference on Alzheimer’s and Dementia Diseases, which is going to be held on the 21st and 22nd days of July 2025 in the vibrant city, Vancouver, Canada. This premier event, under the theme “Innovations and Advances in Alzheimer’s and Dementia Research,” is going to be an event for gathering the elite of the whole world for the Alzheimer Diseases Summit and the International Dementia Conference 2025.
This Dementia Diseases Conference 2025 is truly a unique platform for ground-breaking ideas, new advancements being published, and potential collaborations in regard to research on Alzheimer’s and dementia. Reserve your spot at this significant Alzheimer’s Diseases Conference 2025 for being in a transformative discussion with cutting-edge innovations that will shape the future of dementia care.
Scientific Sessions
Alzheimer’s disease pathogenesis involves abnormal protein accumulation, leading to neurodegeneration and cognitive decline.
Related Conferences:
Alzheimers Diseases summit | International Dementia Conference
Genetic factors, including APOE variants, significantly influence Alzheimer’s disease susceptibility and progression.
Related Conferences:
Dementia Diseases Conference | Alzheimers Diseases conference
Risk factors include age, genetics, cardiovascular health, and lifestyle habits impacting dementia’s development.
Related Conferences:
Alzheimers and Dementia Diseases Conference | Alzheimer’s disease and Dementia Meetings
Early diagnosis of Alzheimer’s improves treatment outcomes, focusing on biomarkers and cognitive assessment.
Related Conferences:
Neuroinflammation accelerates dementia progression, with immune response playing a critical role in Alzheimer’s pathology.
Related Conferences:
Sleep disturbances are linked to Alzheimer’s, affecting brain detoxification and accelerating cognitive decline.
Related Conferences:
Parkinson’s Disease Conferences | Neuropharmacology Conferences
Dementia care requires comprehensive management, addressing cognitive, behavioral, and emotional needs of patients.
Related Conferences:
neurodegenerative disease Conference | Parkinson’s Disease Meetings
Therapies target amyloid plaques, tau proteins, and neuroinflammation in Alzheimer’s disease treatments.
Related Conferences:
Healthy lifestyle choices, including exercise and diet, reduce dementia risk and improve cognitive health.
Related Conferences:
Current therapies for Alzheimer’s aim to slow disease progression and improve patient quality of life.
Related Conferences:
Venue Attractions
- Connecting Rooms
- Hot breakfast
- Free WiFi
- Concierge
- Non-smoking rooms
- Digital Key
- On-site restaurant
- Fitness center
- Express Mail
- Pet-friendly rooms
- Room service
- Meeting rooms
Get in Touch
Address
16192 Coastal Highway Lewes, Delaware, USA 19958
Phone number
+1 630 768 1199
E-mail address
support@stripeconferences.com
Media Partners
CONTACT US
Error: Contact form not found.
Frequently Asked Questions (FAQS)
Researchers, neurologists, healthcare professionals, and specialists in dementia management should attend this International Alzheimers Conference.
Age, genetics, cardiovascular health, and lifestyle are the primary risk factors discussed at the Dementia Diseases Conference 2025.
Therapeutic targets include amyloid plaques, tau proteins, and neuroinflammation, explored at the Alzheimers Diseases Conference 2025.
Neuroimaging techniques, such as MRI and PET scans, are crucial for early diagnosis and monitoring of Alzheimer’s disease.
Neuroinflammation contributes to disease progression, with treatment strategies discussed at the International Dementia Conference.